Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Oversight of the Individually Tailored Treatment Approach: A Novel Pilot Study

NCT04801966 is registered in ClinicalTrials.gov with Peter MacCallum Cancer Centre, Australia as lead sponsor.

NCT NCT04801966
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04801966 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Oversight of the Individually Tailored Treatment Approach: A Novel Pilot Study
Lead sponsor
Peter MacCallum Cancer Centre, Australia
Phase
Not applicable
Overall status
Terminated
Start date
September 23, 2021
Completion date
December 30, 2022
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer